Upcoming catalysts and material SEC filings for Alto Neuroscience, Inc. (ANRO). 2 upcoming catalysts.
Trial readout (estimated)
Q1 2027 · Estimated — subject to change
Trial readout (estimated)
Q3 2027 · Estimated — subject to change
Extracted from the company's SEC 8-K filings (EDGAR). Estimated dates can change.
SEC EDGAR · 17d ago